• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000254
Device Problems No Device Output (1435); Unable to Obtain Readings (1516); Failure to Calibrate (2440)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/10/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the intra-aortic balloon (iab) was opened to be used and when connected intra-aortic balloon pump (iabp), the c alibration key did not calibrate.After several times trying with no success, a new iab was opened and was successfully calibrated.The staff only wanted to use the fiber technology.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Event Description
It was reported that the intra-aortic balloon (iab) was opened to be used and when connected intra-aortic balloon pump (iabp), the calibration key did not calibrate.After several times trying with no success, a new iab was opened and was successfully calibrated.The staff only wanted to use the fiber technology.This report would not be likely to cause or contribute to a death or serious injury.A fiber optic sensor (fos) not connecting cannot in itself cause or contribute to a patient death or serious injury.The fos is a portion of the catheter that monitors the patient's arterial pressure.When the fiber optic pressure signal is not available, the intra-aortic balloon (iab) is still able to be used since an arterial pressure signal is available through the central lumen.Iab therapy continues to the patient uninterrupted.This system does not require the clinician to remove the iab in the event that the fos is lost.It was reported that there was no patient injury or consequence.Although, a delay while another iab is obtained this is unlikely, to cause or contribute to patient injury.
 
Manufacturer Narrative
(b)(4).No iab parts was returned to teleflex chelmsford for investigation.The reported complaint of iab fos would not calibrate is not able to be confirmed.The product was not returned for investigation.If the product is returned at a later date, a full investigation of the sample will be completed.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.
 
Event Description
It was reported that the intra-aortic balloon (iab) was opened to be used and when connected intra-aortic balloon pump (iabp), the c alibration key did not calibrate.After several times trying with no success, a new iab was opened and was successfully calibrated.The staff only wanted to use the fiber technology.This report would not be likely to cause or contribute to a death or serious injury.A fiber optic sensor (fos) not connecting cannot in itself cause or contribute to a patient death or serious injury.The fos is a portion of the catheter that monitors the patient's arterial pressure.When the fiber optic pressure signal is not available, the intra-aortic balloon (iab) is still able to be used since an arterial pressure signal is available through the central lumen.Iab therapy continues to the patient uninterrupted.This system does not require the clinician to remove the iab in the event that the fos is lost.It was reported that there was no patient injury or consequence.Although, a delay while another iab is obtained this is unlikely, to cause or contribute to patient injury.
 
Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint of iab fos would not calibrate is not confirmed.The cal key and fos connection of the returned iab was intact and functional; the reported complaint could not be replicated during functional testing.The returned device passed visual and functional test specifications.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key9173143
MDR Text Key182784264
Report Number3010532612-2019-00363
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902007247
UDI-Public00801902007247
Combination Product (y/n)N
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 09/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/09/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Model NumberIPN000254
Device Catalogue NumberIAB-05840-LWS
Device Lot Number18F18D0062
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/07/2020
Date Manufacturer Received06/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
N/A.; N/A.; N/A.
Patient Age62 YR
-
-